Q523--Brand Name or Equal to the American Red Cross - Autologous Transfusion Cell Saver Unrestricted | POP: 05/01/26-04/30/27.

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 is soliciting bids for Autologous Transfusion Cell Saver services at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. The contractor will be responsible for providing FDA-approved cell saver equipment, disposable supplies, and qualified personnel (registered nurses or certified technicians) to support basic and mini autotransfusion procedures across multiple surgical specialties. Key requirements include maintaining two cell-saving machines in the operating room, providing 24/7 coverage with a 30-minute response time to notifications, and delivering comprehensive reporting and quality management services. The contract will be awarded on a Lowest Price Technically Acceptable (LPTA) basis. The solicitation was issued on November 21, 2025, with quotes due by December 5, 2025, at 4:00 PM EST.

This is an unrestricted procurement with no set-aside designation, meaning any qualified vendor may compete. The contract period runs from May 1, 2026, through April 30, 2027, with an estimated value of approximately $40 million. The solicitation references the American Red Cross as the brand name or equal standard, indicating that comparable alternatives to the incumbent provider may be considered. Performance will be executed at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The one-year service contract encompasses all autologous transfusion procedures performed at the facility during the performance period.